Experience
Michael Mann, Ph.D.
National Review et al.
Along with co-counsel from Williams Lapatto and Cozen O’Connor, represented Dr. Mann in prosecuting defamation claims against defendants Mark Steyn (writing for National Review) and Rand Simberg (writing for Competitive Enterprise Institute) for statements personally attacking Dr. Mann in an effort to denigrate the established scientific consensus that human activity is causing climate change. Secured favorable jury verdict, including punitive damages, against defendants.
Michael Mann, Ph.D. v. National Review et al., 2012-CA-008263-B, District of Columbia Superior Court, Judge Irving
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
Sandoz, Inc. et al v. Pharmacyclics LLC
Pharmacyclics LLC; Janssen Biotech, Inc.
Sequenom, Inc. et al
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
AbbVie Inc.
Koninklijke Philips NV et al. v. Tongfang Global Inc. et al.
Koninklijke Philips NV et al.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.